Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg in a Continuous Daily Regimen for Oral Contraception

To evaluate the safety and contraceptive efficacy of an oral contraceptive containing a combination of LNG 90 mg/EE 20 mg in a continuous-use regimen.

Inclusion Criteria:

• Healthy women aged 18 to 49 years
• Regular (21- to 35- day) menstrual cycles for the 3-month period preceding visit 1
• Must be sexually active and at risk for becoming pregnant.

Exclusion Criteria:

• Planned use of any other form of birth control other than the test article.
• Depression requiring hospitalization or associated with suicidal ideation within the last 3 years.
• High blood pressure (defined as elevated sitting blood pressure: > 140/90 mm Hg).